Genetic and molecular mechanisms dysregulating CD4 T cell tolerance in organ-specific autoimmunity
Genetic and molecular mechanisms dysregulating CD4 T cell tolerance in organ-specific autoimmunity
批准号:
nhmrc : 366772
负责人:
Prof Christopher Goodnow
金额:
$38.4万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project will analyse mechanisms that regulate CD4 T cells and normally prevent the immune system from attacking parts of our own body. Unknown errors in the control of T cells result in autoimmune diseases such as Type 1 diabetes, multiple sclerosis, Addison s disease and thyroid disease, where T cells damage or destroy vital organs. In order to develop rational, specific methods for treating and preventing these diseases, it is necessary to identify and understand the genetic and biochemical mechanisms that normally control T cell responses to self components, and how inherited defects lead these mechanisms to break down. The project focuses on defining how CD4 T cell regulation breaks down in a well established but poorly understood example of polygenic inherited susceptibility to autoimmune disease. Polygenic diseases are those where susceptibility is inherited in a complex way involving many different genes either acting together or in opposition, and the molecular basis for this kind of inheritance is particularly poorly understood. The project will analyse the basis for this kind of inheritance pattern by analysing the direct action of diabetes susceptibility genes at the level of the specific T cells responsible for autoimmune attack and in terms of the biochemical pathways within the T cells that are dysregulated. By identifying the mechanisms and biochemical pathways that are dysregulated in autoimmune disorders, the results of this project will concepts and targets for understanding and diagnosing autoimmune diseases and for developing new drugs or vaccines to prevent T cells damaging vital organs and cure these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunological diseases: understanding their cause and improving their treatment by human genome sequencing
-
批准号:nhmrc : 1081858
-
项目类别:Research Fellowships
-
资助金额:$52.58万
-
财政年份:2015
-
负责人:Prof Christopher Goodnow
-
依托单位:
Immunological diseases: understanding their cause and improving their treatment by human genome sequencing
-
批准号:nhmrc : GNT1081858
-
项目类别:Research Fellowships
-
资助金额:$83.69万
-
财政年份:2015
-
负责人:Prof Christopher Goodnow
-
依托单位:
Australia Fellowship
-
批准号:nhmrc : 585490
-
项目类别:NHMRC Research Fellowships
-
资助金额:$266.72万
-
财政年份:2010
-
负责人:Prof Christopher Goodnow
-
依托单位:
Autoimmune Polyendocrine Syndrome Type 1 - A rare disorder of childhood as a model of autoimmunity
-
批准号:nhmrc : 410230
-
项目类别:NHMRC Strategic Awards
-
资助金额:$33.8万
-
财政年份:2007
-
负责人:Prof Christopher Goodnow
-
依托单位:
Discovering genes and mechanisms regulating immune responses
-
批准号:FF0669149
-
项目类别:Federation Fellowships
-
资助金额:$76.32万
-
财政年份:2007
-
负责人:Prof Christopher Goodnow
-
依托单位:
Mechanisms controlling antibody production by modulating B cell antigen receptor signalling
-
批准号:nhmrc : 366771
-
项目类别:NHMRC Project Grants
-
资助金额:$35.78万
-
财政年份:2006
-
负责人:Prof Christopher Goodnow
-
依托单位:
Australian Phenome Bank
-
批准号:nhmrc : 268084
-
项目类别:NHMRC Enabling Grants
-
资助金额:$152.12万
-
财政年份:2004
-
负责人:Prof Christopher Goodnow
-
依托单位:
Genetic and biochemical mechanisms dysregulating CD4 T cell tolerance in organ-specific autoimmunity
-
批准号:nhmrc : 224265
-
项目类别:NHMRC Project Grants
-
资助金额:$30.41万
-
财政年份:2003
-
负责人:Prof Christopher Goodnow
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: